HK1138504A1 - 放射性診斷顯像劑的製備方法 - Google Patents
放射性診斷顯像劑的製備方法Info
- Publication number
- HK1138504A1 HK1138504A1 HK10104126.7A HK10104126A HK1138504A1 HK 1138504 A1 HK1138504 A1 HK 1138504A1 HK 10104126 A HK10104126 A HK 10104126A HK 1138504 A1 HK1138504 A1 HK 1138504A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- production
- imaging agent
- diagnostic imaging
- radiation diagnostic
- radiation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C229/48—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
- A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/001—Acyclic or carbocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B63/00—Purification; Separation; Stabilisation; Use of additives
- C07B63/04—Use of additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007031692 | 2007-02-13 | ||
PCT/JP2008/052231 WO2008099800A1 (ja) | 2007-02-13 | 2008-02-12 | 放射性画像診断剤の製造方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1138504A1 true HK1138504A1 (zh) | 2010-08-27 |
Family
ID=39690029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10104126.7A HK1138504A1 (zh) | 2007-02-13 | 2010-04-28 | 放射性診斷顯像劑的製備方法 |
Country Status (10)
Country | Link |
---|---|
US (2) | US8343459B2 (zh) |
EP (1) | EP2119458B9 (zh) |
JP (1) | JP5258583B2 (zh) |
KR (1) | KR101485445B1 (zh) |
CN (1) | CN101636183B (zh) |
CA (1) | CA2678020C (zh) |
ES (1) | ES2421886T3 (zh) |
HK (1) | HK1138504A1 (zh) |
TW (1) | TWI406674B (zh) |
WO (1) | WO2008099800A1 (zh) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080071146A (ko) | 2005-11-29 | 2008-08-01 | 니혼 메디피직스 가부시키가이샤 | 방사성 할로겐 표식 유기 화합물의 전구체 화합물 |
WO2008056481A1 (fr) * | 2006-11-09 | 2008-05-15 | Nihon Medi-Physics Co., Ltd. | Agent d'imagerie de diagnostic radioactif |
PL2106808T3 (pl) * | 2006-12-21 | 2018-07-31 | Nihon Medi-Physics Co., Ltd. | Promieniotwórczy znacznik do obrazowania diagnostycznego zawierający kwas 1-amino-3-[18F]fluorocyklobutanokarboksylowy |
CN101636183B (zh) * | 2007-02-13 | 2014-03-19 | 日本医事物理股份有限公司 | 放射性诊断显像剂的制备方法 |
BRPI0820438A2 (pt) * | 2007-11-07 | 2015-06-16 | Ge Healthcare Bv | Composição radiofarmacêutica estabilizada, método para a preparação da mesma, e, uso de ácido gentísico ou um sal do mesmo com um cátion biocompatível. |
DK2419096T3 (da) | 2009-04-15 | 2020-02-03 | Lantheus Medical Imaging Inc | Stabilisering af radiofarmaceutiske sammensætninger under anvendelse af ascorbinsyre |
CN108218650A (zh) * | 2010-12-29 | 2018-06-29 | 通用电气健康护理有限公司 | 洗脱溶液 |
EP2793954B1 (en) * | 2011-12-21 | 2020-10-21 | GE Healthcare Limited | 18f-fluciclovine compositions in citrate buffers |
US20130005958A1 (en) * | 2011-06-30 | 2013-01-03 | General Electric Company | Devices and methods for reducing radiolysis of radioisotopes |
US20130004414A1 (en) * | 2011-06-30 | 2013-01-03 | General Electric Company | Devices and methods for reducing radiolysis of radioisotopes |
US11534494B2 (en) | 2011-12-21 | 2022-12-27 | Ge Healthcare Limited | Formulation and method of synthesis |
GB201411569D0 (en) | 2014-06-30 | 2014-08-13 | Ge Healthcare Ltd | Novel formulation and method of synthesis |
GB201209082D0 (en) * | 2012-05-24 | 2012-07-04 | Ge Healthcare Ltd | Purification method |
GB201214220D0 (en) | 2012-08-09 | 2012-09-19 | Ge Healthcare Ltd | Radiosynthesis |
GB2561122B (en) * | 2012-12-21 | 2019-07-17 | Ge Healthcare Ltd | Composition comprising [18F]-Fluciclovine |
GB201305687D0 (en) * | 2013-03-28 | 2013-05-15 | Ge Healthcare Ltd | Radiolabelling process |
GB201322451D0 (en) * | 2013-12-18 | 2014-02-05 | Ge Healthcare Ltd | Purification method and compositions |
US10695450B2 (en) | 2016-07-26 | 2020-06-30 | Laboratoires Cyclopharma | Synthesis of a radioactive agent composition |
DE102016012552A1 (de) * | 2016-10-20 | 2018-04-26 | Carl Freudenberg Kg | Dichtung und Dichtungsanordnung |
JP7260552B2 (ja) * | 2018-01-24 | 2023-04-18 | エーシー・イミューン・エス・アー | Pet画像化のための診断用組成物、診断用組成物を製造するための方法及び診断におけるその使用 |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4871745A (en) | 1986-09-22 | 1989-10-03 | Ortho Pharmaceutical Corporation | 2- or 3-aryl substituted imidazo(1,2-A)pyridines and their use as antisecretory agents |
US4833149A (en) | 1986-09-22 | 1989-05-23 | Ortho Pharmaceutical Corporation | 2- or 3-aryl substituted imidazo[1,2-a]pyridines |
US4727145A (en) | 1986-09-22 | 1988-02-23 | Ortho Pharmaceutical Corporation | 2- Or 3- aryl substituted imidazo [1,2-a]pyridines |
US4791117A (en) | 1986-09-22 | 1988-12-13 | Ortho Pharmaceutical Corporation | 2- or 3-aryl substituted imidazo[1,2-a]pyridines and their use as calcium channel blockers |
DE4327027A1 (de) | 1993-02-15 | 1994-08-18 | Bayer Ag | Imidazoazine |
BR9611047A (pt) | 1995-10-17 | 2000-03-08 | Searle & Co | Processo de deteção de ciclo oxigenase-2 |
US5808146A (en) | 1995-11-09 | 1998-09-15 | Emory University | Amino acid analogs for tumor imaging |
US6027710A (en) | 1996-09-18 | 2000-02-22 | Nihon Medi-Physiscs Co., Ltd. | Radiation-protecting agent |
JP4242465B2 (ja) | 1996-09-18 | 2009-03-25 | 日本メジフィジックス株式会社 | 放射線防護剤 |
US6812327B1 (en) | 1996-10-25 | 2004-11-02 | Human Genome Sciences, Inc. | Neutrokine-alpha polypeptides |
US6274119B1 (en) | 1998-08-20 | 2001-08-14 | The Regents Of The Univ. Of California | Methods for labeling β-amyloid plaques and neurofibrillary tangles |
JP4025468B2 (ja) | 1999-07-29 | 2007-12-19 | 三井化学株式会社 | 有機電界発光素子 |
WO2001074813A2 (en) | 2000-03-31 | 2001-10-11 | Ortho Mcneil Pharmaceutical, Inc. | METHOD FOR USING 2- OR 3-ARYL SUBSTITUTED IMIDAZO[1,2-a] PYRIDINES AS H3 ANTAGONISTS |
US6908929B2 (en) | 2000-03-31 | 2005-06-21 | Ortho-Mcneil Pharmaceutical, Inc. | Phenyl-substituted imidazopyridines |
US20010051632A1 (en) | 2000-03-31 | 2001-12-13 | Wenying Chai | Phenyl-substituted indolizines and tetrahydroindolizines |
DE10040016A1 (de) | 2000-08-16 | 2002-02-28 | Boehringer Ingelheim Pharma | Neue beta-Amyloid Inhibitoren, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
US6514969B2 (en) | 2000-08-16 | 2003-02-04 | Boehringer Ingelheim Pharma Kg | β-amyloid inhibitors, processes for preparing them, and their use in pharmaceutical compositions |
EP1334091B1 (en) | 2000-08-24 | 2012-09-19 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Thioflavin derivatives and their use in diagnosis and therapy of alzheimer's disease |
IL157359A0 (en) | 2001-02-26 | 2004-02-19 | Bristol Myers Squibb Pharma Co | A radiopharmaceutical composition containing an ascorbic acid analog |
US6596731B2 (en) | 2001-03-27 | 2003-07-22 | Hoffmann-La Roche Inc. | Substituted imidazo[1,2-A] pyridine derivatives |
AU2002258915B2 (en) | 2001-04-23 | 2007-11-15 | The Trustees Of The University Of Pennsylvania | Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
IL158667A0 (en) | 2001-06-21 | 2004-05-12 | Smithkline Beecham Corp | Imidazo [1,2-a] pyridine derivatives for the prophylaxis and treatment of herpes viral infections |
EP1432453B1 (en) | 2001-08-27 | 2013-08-14 | The Trustees of The University of Pennsylvania | Stilbene derivatives and their use for binding and imaging amyloid plaques |
GB0205281D0 (en) | 2002-03-06 | 2002-04-17 | Novartis Ag | Organic compounds |
EP1356827A1 (en) * | 2002-04-24 | 2003-10-29 | Mallinckrodt Inc. | Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG)-solution |
US7563433B2 (en) * | 2007-01-11 | 2009-07-21 | Immunomedics, Inc. | Methods and compositions for F-18 labeling of proteins, peptides and other molecules |
ES2347535T3 (es) | 2002-11-05 | 2010-11-02 | Ion Beam Applications S.A. | Estabilizacion de composiciones acuosas de 2-fluoro-2-desoxi-d-glucosa marcada con el isotopo 18f con etanol. |
GB0229695D0 (en) * | 2002-12-20 | 2003-01-29 | Amersham Plc | Solid-phase preparation of 18F-labelled amino acids |
AU2004312506B2 (en) | 2003-12-31 | 2011-08-04 | Schering-Plough Pty. Limited | Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivatives |
GB0422004D0 (en) | 2004-10-05 | 2004-11-03 | Amersham Plc | Method of deprotection |
CN101180272B (zh) * | 2005-05-23 | 2012-04-25 | 日本医事物理股份有限公司 | 有机化合物及利用该化合物的放射性卤素标记有机化合物的制造方法 |
CN101198359B (zh) * | 2005-06-14 | 2011-06-22 | 日本医事物理股份有限公司 | 放射性诊断成像剂 |
EP1893246A4 (en) | 2005-06-23 | 2009-05-06 | Univ Emory | STEREOSELECTIVE SYNTHESIS OF AMINO ACID ANALOGUE FOR TUMOR IMAGING |
CA2651786C (en) | 2006-05-11 | 2014-11-04 | Nihon Medi-Physics Co., Ltd. | Process for production of radioactive fluorine-labeled organic compound |
NZ573363A (en) | 2006-05-19 | 2012-01-12 | Nihon Mediphysics Co Ltd | Compound having affinity for amyloid based on an imidazopyridine-phenyl skeleton |
JP4273133B2 (ja) | 2006-05-31 | 2009-06-03 | キヤノン株式会社 | デジタル放送受信装置、デジタル放送受信装置の制御方法、及びプログラム |
WO2008056481A1 (fr) | 2006-11-09 | 2008-05-15 | Nihon Medi-Physics Co., Ltd. | Agent d'imagerie de diagnostic radioactif |
PL2106808T3 (pl) * | 2006-12-21 | 2018-07-31 | Nihon Medi-Physics Co., Ltd. | Promieniotwórczy znacznik do obrazowania diagnostycznego zawierający kwas 1-amino-3-[18F]fluorocyklobutanokarboksylowy |
CN101636183B (zh) * | 2007-02-13 | 2014-03-19 | 日本医事物理股份有限公司 | 放射性诊断显像剂的制备方法 |
AU2008314870A1 (en) | 2007-10-24 | 2009-04-30 | Nihon Medi-Physics Co., Ltd. | Novel compound having affinity for amyloid |
KR20100072344A (ko) | 2007-10-26 | 2010-06-30 | 니혼 메디피직스 가부시키가이샤 | 신규 아밀로이드 친화성 화합물 |
JPWO2009057578A1 (ja) | 2007-10-30 | 2011-03-10 | 日本メジフィジックス株式会社 | 新規アミロイド親和性化合物の使用及び製造方法 |
-
2008
- 2008-02-12 CN CN200880008655.6A patent/CN101636183B/zh active Active
- 2008-02-12 CA CA2678020A patent/CA2678020C/en active Active
- 2008-02-12 KR KR1020097017131A patent/KR101485445B1/ko active IP Right Grant
- 2008-02-12 WO PCT/JP2008/052231 patent/WO2008099800A1/ja active Application Filing
- 2008-02-12 EP EP08711095.3A patent/EP2119458B9/en active Active
- 2008-02-12 ES ES08711095T patent/ES2421886T3/es active Active
- 2008-02-12 US US12/526,667 patent/US8343459B2/en active Active
- 2008-02-12 JP JP2008558082A patent/JP5258583B2/ja active Active
- 2008-02-12 TW TW097104810A patent/TWI406674B/zh active
-
2010
- 2010-04-28 HK HK10104126.7A patent/HK1138504A1/zh unknown
-
2012
- 2012-08-02 US US13/565,204 patent/US8658132B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN101636183B (zh) | 2014-03-19 |
US20100119448A1 (en) | 2010-05-13 |
CA2678020C (en) | 2015-03-24 |
EP2119458A1 (en) | 2009-11-18 |
JPWO2008099800A1 (ja) | 2010-05-27 |
EP2119458B9 (en) | 2013-08-21 |
TWI406674B (zh) | 2013-09-01 |
US8343459B2 (en) | 2013-01-01 |
KR20090111331A (ko) | 2009-10-26 |
KR101485445B1 (ko) | 2015-01-22 |
TW200833362A (en) | 2008-08-16 |
US20120301399A1 (en) | 2012-11-29 |
US8658132B2 (en) | 2014-02-25 |
ES2421886T3 (es) | 2013-09-06 |
EP2119458B1 (en) | 2013-05-15 |
CN101636183A (zh) | 2010-01-27 |
JP5258583B2 (ja) | 2013-08-07 |
EP2119458A4 (en) | 2010-03-24 |
CA2678020A1 (en) | 2008-08-21 |
WO2008099800A1 (ja) | 2008-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1138504A1 (zh) | 放射性診斷顯像劑的製備方法 | |
EP2351353A4 (en) | STRUCTURE OF IMAGEUR DEVICE HOUSING | |
EP2346406A4 (en) | X-RAY IMAGING APPARATUS | |
GB0810051D0 (en) | Method of diagnosis | |
EP2488107A4 (en) | INTRAVASCULAR ULTRASONIC SYSTEM FOR COREGISTERED IMAGE | |
EP1981404A4 (en) | RADIATION IMAGING APPARATUS | |
IL211701A0 (en) | Process for the preparation of bendamustine | |
EP2427111A4 (en) | IMAGING DEVICE FOR 3D COMPUTER TOMOGRAPHY | |
EP2471556A4 (en) | CONTRASTANT FOR PHOTOACUSTIC IMAGING AND PROCESS FOR PHOTOACUSTIC IMAGING THEREWITH | |
GB0706088D0 (en) | X-ray imaging of materials | |
EP2491861A4 (en) | RADIOGRAPHIC IMAGING SYSTEM | |
GB2488732B (en) | Radiographic imaging apparatus | |
EP2221035A4 (en) | INCUBATOR FOR IMAGE DISPLAY WITH NON-ILLUMINATING RADIATION | |
EP2277447A4 (en) | MEDICAL X-RAY GENERATOR | |
GB0706089D0 (en) | X-ray imaging of materials | |
GB0904080D0 (en) | Imaging method | |
EP2340851A4 (en) | DIAGNOSTIC METHOD AND THERAPEUTIC METHOD FOR CANCER | |
GB0804629D0 (en) | Imaging apparatus & method | |
HRP20171443T1 (hr) | Postupak za pripremanje jodiranog kontrastnog sredstva | |
GB2479328B (en) | X-ray imaging apparatus and method of X-ray imaging | |
GB2479329B (en) | X-ray imaging apparatus and method of X-ray imaging | |
EP2484267A4 (en) | DEVICE FOR DIAGNOSTIC IMAGING AND METHOD FOR CONTROLLING THEREOF | |
EP2236086A4 (en) | X-RAY IMAGING APPARATUS | |
GB0920839D0 (en) | Contrast agents for medical imaging | |
EP2287604A4 (en) | METHOD FOR THE STUDY OF MORBUS ALZHEIMER |